{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:06:34Z","timestamp":1769051194490,"version":"3.49.0"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,6,18]]},"DOI":"10.18632\/aging.103324","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T19:36:33Z","timestamp":1592508993000},"page":"11623-11635","source":"Crossref","is-referenced-by-count":25,"title":["Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p\/LAMC2 axis"],"prefix":"10.18632","volume":"12","author":[{"given":"Jinglan","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreas Surgery, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meishan","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreas Surgery, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we?","volume":"6","author":"Kanwal","year":"2014","journal-title":"where do we go? Hepatology"},{"key":"2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12964-019-0456-x","article-title":"Karyopherin \u03b12-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.","volume":"1","author":"Singer","year":"2019","journal-title":"Cell Commun Signal"},{"key":"3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma.","volume":"15","author":"Sherman","year":"2016","journal-title":"Gastroenterology"},{"key":"4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000333259","article-title":"Adjuvant therapy after curative treatment for hepatocellular carcinoma.","volume":"8","author":"Kudo","year":"2011","journal-title":"Oncology"},{"key":"5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency.","volume":"49","author":"Landthaler","year":"2013","journal-title":"Nature"},{"key":"6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","article-title":"Circular RNAs in cancer: opportunities and challenges in the field.","volume":"3","author":"Kjems","year":"2018","journal-title":"Oncogene"},{"key":"7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1096\/fasebj.7.1.7678559","article-title":"Mis-splicing yields circular RNA molecules.","volume":"7","author":"Bailleul","year":"1993","journal-title":"FASEB J"},{"key":"8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41419-019-2089-9","article-title":"CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.","volume":"1","author":"Fan","year":"2019","journal-title":"Cell Death Dis"},{"key":"9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3389\/fonc.2019.01105","article-title":"Up-regulation of hsa_circ_0000517 predicts adverse prognosis of hepatocellular carcinoma.","volume":"9","author":"Chen","year":"2019","journal-title":"Front Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","article-title":"Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.","volume":"6","author":"Cao","year":"2017","journal-title":"Hepatology"},{"key":"11","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.7150\/jca.32927","article-title":"CircRNAs and its relationship with gastric cancer.","volume":"1","author":"Xu","year":"2019","journal-title":"J Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"e18042","DOI":"10.1097\/MD.0000000000018042","article-title":"Identification of breast cancer-related circRNAs by analysis of microarray and RNA-sequencing data: an observational study.","volume":"9","author":"Qu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s13046-019-1436-0","article-title":"circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma.","volume":"3","author":"Wang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.26355\/eurrev_201910_19271","article-title":"Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS.","volume":"2","author":"Wang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"15","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.2147\/OTT.S220700","article-title":"Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer.","volume":"1","author":"Liu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"16","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jcp.29092","article-title":"Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p\/FGFR1\/ERK axis.","volume":"23","author":"Hu","year":"2020","journal-title":"J Cell Physiol"},{"key":"17","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.7150\/thno.32796","article-title":"Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma.","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fonc.2019.00392","article-title":"CircRNA-100338 is associated with mTOR signaling pathway and poor prognosis in hepatocellular carcinoma.","volume":"9","author":"Tang","year":"2019","journal-title":"Front Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the rosetta stone of a hidden RNA language?","volume":"14","author":"Pandolfi","year":"2011","journal-title":"Cell"},{"key":"20","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.26355\/eurrev_201908_18543","article-title":"MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1\u03b1-mediated VEGF signaling pathway.","volume":"2","author":"Zhang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2147\/OTT.S192377","article-title":"The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1\u03b1\/VEGF pathway in vitro and vivo.","volume":"1","author":"Cao","year":"2019","journal-title":"Onco Targets Ther"},{"key":"22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/cbr.2016.1995","article-title":"Decreased expression of miR-548c-3p in osteosarcoma contributes to cell proliferation via targeting ITGAV.","volume":"3","author":"Ma","year":"2016","journal-title":"Cancer Biother Radiopharm"},{"key":"23","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.2147\/CMAR.S171912","article-title":"Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma.","volume":"1","author":"Huang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41418-018-0084-9","article-title":"LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.","volume":"2","author":"Bai","year":"2018","journal-title":"Cell Death Differ"},{"key":"25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cas.13502","article-title":"Protocadherin-8 promotes invasion and metastasis via laminin subunit \u03b32 in gastric cancer.","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Sci"},{"key":"26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/jop.12677","article-title":"LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.","volume":"4","author":"Yang","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"27","doi-asserted-by":"publisher","first-page":"1010428317705849","DOI":"10.1177\/1010428317705849","article-title":"Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion.","volume":"3","author":"Gu","year":"2017","journal-title":"Tumour Biol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.ajpath.2019.03.012","article-title":"Silencing of LAMC2 reverses epithelial-mesenchymal transition and inhibits angiogenesis in cholangiocarcinoma via inactivation of the epidermal growth factor receptor signaling pathway.","volume":"18","author":"Liu","year":"2019","journal-title":"Am J Pathol"},{"key":"29","doi-asserted-by":"publisher","first-page":"116648","DOI":"10.1016\/j.lfs.2019.116648","article-title":"LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling.","volume":"23","author":"Qiu","year":"2019","journal-title":"Life Sci"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:28:49Z","timestamp":1599078529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,30]]}},"alternative-id":["103324","32554866"],"URL":"https:\/\/doi.org\/10.18632\/aging.103324","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]}}}